Related references
Note: Only part of the references are listed.Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Robert Beetham et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2007)
Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis -: a pilot study
B. Hildebrandt et al.
BMC CANCER (2007)
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis
Frits van Rhee et al.
BLOOD (2007)
Demonstration of changes in plasma cell subsets in multiple myeloma
Michael John Ayliffe et al.
HAEMATOLOGICA (2007)
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
Marie-Christine Kyrtsonis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The serum-free light chain assay cannot replace 24-hour urine protein estimation in patients with plasma cell dyscrasias
Seema Singhal et al.
BLOOD (2007)
Serum-free light chain - a new biomarker for patients with B-cell non-Hodgkin lymphocytic leukemia
William Martin et al.
TRANSLATIONAL RESEARCH (2007)
Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma:: In vitro and in vivo studies
Colin A. Hutchison et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases
Jillian R. Tate et al.
CLINICA CHIMICA ACTA (2007)
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation
Ulrike Moesbauer et al.
HAEMATOLOGICA (2007)
Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains
Mark A. Dawson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Prognostic significance of metallothionein in B-cell lymphomas
Christian Bjorn Poulsen et al.
BLOOD (2006)
Schistosoma mansoni infection in eosinophil lineage-ablated mice
Jonathan M. Swartz et al.
BLOOD (2006)
Immunoglobulin free light chains and solitary plasmacytoma of bone
David Dingli et al.
BLOOD (2006)
Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials
Mark Drayson et al.
BLOOD (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
Giovanni Palladini et al.
BLOOD (2006)
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2006)
Guidelines on the diagnosis and management of multiple myeloma 2005
A Smith et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains
G Pratt et al.
LEUKEMIA & LYMPHOMA (2006)
Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
H Hassoun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Monoclonal gammopathy of undetermined significance
Robert A. Kyle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Serum free light chains: An alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies
Peter G. Hill et al.
CLINICAL CHEMISTRY (2006)
Plasma exchange when myeloma presents as acute renal failure - A randomized, controlled trial
WF Clark et al.
ANNALS OF INTERNAL MEDICINE (2005)
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
V Sanchorawala et al.
BONE MARROW TRANSPLANTATION (2005)
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance
S Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
SV Rajkumar et al.
BLOOD (2005)
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
MA Gertz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Diagnosis and monitoring a case of fight-chain deposition disease in the kidney using a new, sensitive immunoassay
I Brockhurst et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Diagnostic performance of quantitative κ and λ free light chain assays in clinical practice
JA Katzmann et al.
CLINICAL CHEMISTRY (2005)
Serum free light chains for monitoring multiple myeloma
J Tate et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Early response to therapy and survival in multiple myeloma
CG Schaar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Serum free light chains for monitoring multiple myeloma
GP Mead et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Magnitude of response with myeloma frontline therapy does not predict outcome: Importance of time to progression in southwest oncology group chemotherapy trials
BGM Durie et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
HJ Lachmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Serum test for assessment of patients with Bence Jones myeloma
AR Bradwell et al.
LANCET (2003)
Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
C Cesana et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
M Drayson et al.
BLOOD (2001)